Benign breast biopsy diagnosis and subsequent risk of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 3, 2007, Pages 467-472

  Ashbeck, Erin L ^a   Rosenberg, Robert D ^a,b   Stauber, Patricia M ^a   Key, Charles R ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST ADENOSIS; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST CYST; BREAST DISEASE; BREAST HYPERPLASIA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROADENOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTITIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEW MEXICO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK;

EID: 34047270222     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0394     Document Type: Article

References (31)

1. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
2. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-708.
3. Carter CL, Dorle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128:467-77.
4. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301.
5. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-4.
6. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Jr., Simpson JF. Aypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003;361:125-9.
7. Hutter RVP. Consensus meeting: is "fibrocystic disease" of the breast precancerous? Arch Pathol Lab Med 1986;110:171-3.
8. Fitzgibbons PL, Henson DE, Hutter RVP. Benign breast changes and the risk for subsequent breast cancer. Arch Pathol Lab Med 1998;122:1053-5.
9. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 2004;96:616-20.
10. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 1989;20:723-5.
11. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135:619-31.
12. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.
13. Shaaban AM, Sloane JP, West CR, et al. Histopathologic type of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 2002;26:421-30.
14. Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989;64:1977-83.
15. Seidman JD, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer 1996;77:2529-37.
16. Rosenfeld I, Tartter PI, Gajdos C, Hermann G, Bleiweiss I. The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens. Am J Surg 2001;182:1-5.
17. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-5.
18. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-6.
19. King TA, Scharfenberg JC, Smetherman DH, Farkas EA, Bolton JS, Fuhrman GM. A Better understanding of the term radial scar. Am J Surg 2000;180: 428-33.
20. Sanders ME, Dupont WD, Schuyler PA, Simpson JF, Page DL. Interdependence of radial scar and proliferative disease with respect to invasive breast cancer risk in benign breast biopsies. Mod Pathol 2002;15:50.
21. Patterson JA, Scott M, Anderson N, Kirk SJ. Radial scar, complex sclerosing lesion, and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 2004;30:1065-8.
22. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roentgenol 1997;169:1001-8.
23. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003;27:836-41.
24. Saftlas AF, Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 1987;9:146-74.
25. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15:196-208.
26. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;12: 1133-44.
27. Boyd NF, Jensen HM, Cooke G, Lee Han H, Lockwood GA, Miller A; Reference Pathologists of the Canadian National Breast Screening Study. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Eur J Cancer Prev 2000;9:15.
28. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 2005;7:R605-8.
29. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Path 1991;15: 209-21.
30. Bodian CA, Perzin KH, Lattes R, et al. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer 1993;71:3908-13.
31. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.